好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Characterization of Signal Transduction Pathways Involved in Glatiramer Acetate (GA, Copolymer-1, Copaxone[acirc])-Induced Type II Monocyte Differentiation
MS and Related Diseases
(-)
002
Authors/Disclosures
Nicolas Molnarfi No disclosure on file
Thomas E. Prod'Homme, PhD (Momenta Pharmaceuticals) No disclosure on file
Jean-Pascal Lefaucheur (Faculte De Medecine De Creteil) No disclosure on file
Martin Weber, MD (Universitätsmedizin Göttingen) Dr. Weber has nothing to disclose.
Scott S. Zamvil, MD, PhD, FAAN (University of CA, San Francisco) Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
Bridgette J. Billioux, MD Dr. Billioux has nothing to disclose.